In vitro reconstitution of mevalonate pathway and targeted engineering of farnesene overproduction in Escherichia coli

Approaches using metabolic engineering and synthetic biology to overproduce terpenoids, such as the precursors of taxol and artemisinin, in microbial systems have achieved initial success. However, due to the lack of steady‐state kinetic information and incomplete understanding of the terpenoid biosynthetic pathway, it has been difficult to build a highly efficient, universal system. Here, we reconstituted the mevalonate pathway to produce farnesene (a precursor of new jet fuel) in vitro using purified protein components. The information from this in vitro reconstituted system guided us to rationally optimize farnesene production in E. coli by quantitatively overexpressing each component. Targeted proteomic assays and intermediate assays were used to determine the metabolic status of each mutant. Through targeted engineering, farnesene production could be increased predictably step by step, up to 1.1 g/L (∼2,000 fold) 96 h after induction at the shake‐flask scale. The strategy developed to release the potential of the mevalonate pathway for terpenoid overproduction should also work in other multistep synthetic pathways. Biotechnol. Bioeng. 2014;111: 1396–1405. © 2014 Wiley Periodicals, Inc.

[1]  Jay D. Keasling,et al.  Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin , 2012, Proceedings of the National Academy of Sciences.

[2]  Farren J. Isaacs,et al.  Programming cells by multiplex genome engineering and accelerated evolution , 2009, Nature.

[3]  C. Poulter,et al.  Zinc is an essential cofactor for type I isopentenyl diphosphate:dimethylallyl diphosphate isomerase. , 2003, Journal of the American Chemical Society.

[4]  C. Khosla,et al.  Quantitative analysis and engineering of fatty acid biosynthesis in E. coli. , 2010, Metabolic engineering.

[5]  P. León,et al.  The plastidial MEP pathway: unified nomenclature and resources. , 2008, Trends in plant science.

[6]  J. Keasling,et al.  Engineering dynamic pathway regulation using stress-response promoters , 2013, Nature Biotechnology.

[7]  J. Keasling,et al.  Application of targeted proteomics to metabolically engineered Escherichia coli , 2012, Proteomics.

[8]  J. Goldstein,et al.  Regulation of the mevalonate pathway , 1990, Nature.

[9]  J. Keasling,et al.  Engineering a mevalonate pathway in Escherichia coli for production of terpenoids , 2003, Nature Biotechnology.

[10]  H. Sahm,et al.  Isoprenoid biosynthesis in bacteria: a novel pathway for the early steps leading to isopentenyl diphosphate. , 1993, The Biochemical journal.

[11]  J. Keasling,et al.  Microbial engineering for the production of advanced biofuels , 2012, Nature.

[12]  U. Stahl,et al.  Overexpression of a cytosolic hydroxymethylglutaryl-CoA reductase leads to squalene accumulation in yeast , 1998, Applied Microbiology and Biotechnology.

[13]  Keith E. J. Tyo,et al.  Terpenoids: opportunities for biosynthesis of natural product drugs using engineered microorganisms. , 2008, Molecular pharmaceutics.

[14]  Eui-Sung Choi,et al.  Metabolic engineering of Escherichia coli for α-farnesene production. , 2011, Metabolic engineering.

[15]  Jay D. Keasling,et al.  Identification and microbial production of a terpene-based advanced biofuel , 2011, Nature communications.

[16]  Gabriel C. Wu,et al.  Synthetic protein scaffolds provide modular control over metabolic flux , 2009, Nature Biotechnology.

[17]  Jay D Keasling,et al.  Metabolic engineering of microbial pathways for advanced biofuels production. , 2011, Current opinion in biotechnology.

[18]  W. R. Farmer,et al.  Improving lycopene production in Escherichia coli by engineering metabolic control , 2000, Nature Biotechnology.

[19]  J. Griffiths,et al.  A sensitive mass spectrometric method for hypothesis-driven detection of peptide post-translational modifications: multiple reaction monitoring-initiated detection and sequencing (MIDAS) , 2009, Nature Protocols.

[20]  J. Keasling,et al.  High-level semi-synthetic production of the potent antimalarial artemisinin , 2013, Nature.

[21]  Xueli Zhang,et al.  Engineering central metabolic modules of Escherichia coli for improving β-carotene production. , 2013, Metabolic engineering.

[22]  Zengyi Shao,et al.  DNA assembler, an in vivo genetic method for rapid construction of biochemical pathways , 2008, Nucleic acids research.

[23]  J. Keasling,et al.  High-throughput metabolic engineering: advances in small-molecule screening and selection. , 2010, Annual review of biochemistry.

[24]  D. G. Gibson,et al.  Enzymatic Assembly of Overlapping DNA Fragments , 2011, Methods in Enzymology.

[25]  Tiangang Liu,et al.  In vitro reconstitution and steady-state analysis of the fatty acid synthase from Escherichia coli , 2011, Proceedings of the National Academy of Sciences.

[26]  Yinjie J. Tang,et al.  Central metabolic responses to the overproduction of fatty acids in Escherichia coli based on 13C‐metabolic flux analysis , 2014, Biotechnology and bioengineering.

[27]  Brian F. Pfleger,et al.  Application of Functional Genomics to Pathway Optimization for Increased Isoprenoid Production , 2008, Applied and Environmental Microbiology.

[28]  J. Rabinowitz,et al.  Absolute Metabolite Concentrations and Implied Enzyme Active Site Occupancy in Escherichia coli , 2009, Nature chemical biology.

[29]  Jay D. Keasling,et al.  High-Level Production of Amorpha-4,11-Diene, a Precursor of the Antimalarial Agent Artemisinin, in Escherichia coli , 2009, PloS one.

[30]  J. Rabinowitz,et al.  Absolute quantitation of intracellular metabolite concentrations by an isotope ratio-based approach , 2008, Nature Protocols.

[31]  J. Keasling,et al.  Targeted proteomics for metabolic pathway optimization: application to terpene production. , 2011, Metabolic engineering.

[32]  C. You,et al.  Simple Cloning via Direct Transformation of PCR Product (DNA Multimer) to Escherichia coli and Bacillus subtilis , 2011, Applied and Environmental Microbiology.

[33]  J. Keasling,et al.  Biosynthesis of plant isoprenoids: perspectives for microbial engineering. , 2009, Annual review of plant biology.

[34]  Keith E. J. Tyo,et al.  Isoprenoid Pathway Optimization for Taxol Precursor Overproduction in Escherichia coli , 2010, Science.

[35]  Gregory Stephanopoulos,et al.  Construction of lycopene-overproducing E. coli strains by combining systematic and combinatorial gene knockout targets , 2005, Nature Biotechnology.

[36]  Bruce D. Whitaker,et al.  Cloning and functional expression of an (E,E)-α-farnesene synthase cDNA from peel tissue of apple fruit , 2004, Planta.